首页> 外文学位 >Modulation of the CD161+ Double-Negative T cell Population During Progression of HIV-1 Infection to AIDS is Correlated with an Increased Pro-Inflammatory T cell Gene Expression.
【24h】

Modulation of the CD161+ Double-Negative T cell Population During Progression of HIV-1 Infection to AIDS is Correlated with an Increased Pro-Inflammatory T cell Gene Expression.

机译:在HIV-1感染艾滋病的过程中CD161 +双重阴性T细胞种群的调节与促炎性T细胞基因表达的增加有关。

获取原文
获取原文并翻译 | 示例

摘要

This study characterized CD3+ T cell populations able to secrete IL-17; CD4+, CD8+ and double negative (CD3+CD4-CD8− - DNTs). All CD3 + T cells capable of producing IL-17 are positive for the expression of the surface marker CD161. Using this information, we used flow cytometric methods to characterize these various CD3+ T cell populations in HIV-1 infected patients (n= 36), AIDS patients (n=11) and healthy controls (n=11). The CD4+CD161+ T cells remain relatively stable until reaching the AIDS stage of infection, where there is a dramatic depletion as a percentage of the total CD161+ T cell population (Healthy Controls: 59.67%±6.05 vs. AIDS Group: 40.33%±5.04; p=0.003). The CD8+CD161+ T cell population does not change significantly as a percentage of the total CD161+ population, but the most striking result of our research is that CD161 + DNTs are more than doubled as a percentage of the CD161+ population (Healthy Controls: 12.87%±2.41 vs. AIDS Group: 29.90%±5.17 (p=0.001)). This is significant in that CD161+ DNTs are a highly pro-inflammatory cell population. Secondly, our findings demonstrated that two populations of CD161+DNTs exist; those that are CD3bright and CD3moderate. We concluded that CD3moderateCD161+DNTs were most likely of the α:β-CD3 phenotype, while those CD36brightCD161 +DNTs were likely to be of γδ-CD3 phenotype. Lastly with respect to our flow cytometric data; we noticed a phenomenon we call 'CD8 Drift.' In both our healthy controls and HIV-1 infected populations, the CD4 +CD161+ population is tightly grouped and, with respect to CD4 expression, demonstrates equal brightness to that of the CD4 +CD161− T cells. However, in both our healthy control and patient population, the CD8+CD161+ and CD8+CD161− T cells do not stain equally as bright in regard to CD8 expression. The CD8+CD161 + T cells are scattered broadly across the quadrant, appearing to 'drift' from CD8+ expression to CD8− expression.;In the latter stages of HIV-1 infection, with the CD4+ T cells depleted from the virus, and the CD8+ T cells exhausted due to chronic immune activation, we formed the hypothesis that the increase in these CD161+DNTs represented the human immune systems final effort at producing a pro-inflammatory immune response. To test this we isolated CD3+ T cells from five healthy controls and eight HIV-1 infected patients, and isolated their RNA for use in microarray analysis with qRT-PCR. We predicted that the HIV-1 infected patients with low CD4 counts would have a distinctly pro-inflammatory T cell transcriptional profile as compared to healthy controls. The four HIV-1 infected patients with CD4 counts below 100 showed no positive or negative fold change greater than two, with any of the genes profiled. Of the four HIV patients profiled with CD4 counts between 320 and 101, two showed statistically significant, 2+ fold change (p= <0.001) with respect to the IL-8 gene, while a third patient was very close to significant expression with a p=0.073. The IL-8 cytokine is the major chemoattractant for recruiting polymorphonuclear cells (PMNs) to sites of acute inflammation, and IL-17 is known to act on multiple tissues to induce the secretion of IL-8. Also significantly up-regulated in on the four patients were the GATA-3, CCL20, MMP3, CCL1 and CCL2, though only CCL1 and CCL2 showed a greater than 2+ fold change. Also, in three of the four patients with CD4 counts above 100, there were four genes that had +2 fold changes, and though they never reached the level of significance, they should still be mentioned due to their recurrence in each of the patient's transcriptional profiles. IL-1β, IL-6, CXCL1 and CXCL2 are those genes. All genes that have been listed function to mediate pro-inflammatory immune responses, which support our initial hypothesis that there is a correlation between the increase in CD161+DNTs and the generation of a pro-inflammatory transcriptional profile within the latter stage of an HIV-1 infection. These CD161+DNTs may very well be the body's final attempt at inducing a pro-inflammatory response. (Abstract shortened by UMI.).
机译:这项研究的特征是能够分泌IL-17的CD3 + T细胞群体。 CD4 +,CD8 +和双负(CD3 + CD4-CD8--DNT)。所有能够产生IL-17的CD3 + T细胞表面标记CD161的表达均为阳性。利用这些信息,我们使用流式细胞仪方法对HIV-1感染患者(n = 36),艾滋病患者(n = 11)和健康对照(n = 11)中的各种CD3 + T细胞群体进行了表征。 CD4 + CD161 + T细胞保持相对稳定,直到达到AIDS感染阶段为止,在CD161 + T细胞总数中所占百分比显着减少(健康对照组:59.67%±6.05 vs. AIDS组:40.33%±5.04 ; p = 0.003)。 CD8 + CD161 + T细胞种群占总CD161 +种群的百分比没有显着变化,但我们研究的最惊人结果是CD161 + DNT占CD161 +种群的百分比增加了一倍以上(健康对照:12.87%) ±2.41 vs.AIDS组:29.90%±5.17(p = 0.001)。这很重要,因为CD161 + DNT是高度促炎的细胞群。其次,我们的发现表明存在两个CD161 + DNT。 CD3bright和CD3moderate的那些。我们得出的结论是,CD3中度CD161 + DNTs最可能是α:β-CD3表型,而那些CD36明亮CD161 + DNTs很可能是γδ-CD3表型。最后,关于我们的流式细胞仪数据;我们注意到了一种称为“ CD8漂移”的现象。在我们的健康对照人群和HIV-1感染人群中,CD4 + CD161 +人群紧密分组,就CD4表达而言,其亮度与CD4 + CD161- T细胞相同。但是,在我们的健康对照组和患者群体中,就CD8表达而言,CD8 + CD161 +和CD8 + CD161- T细胞的染色均不一样。 CD8 + CD161 + T细胞散布在整个象限中,似乎从CD8 +表达“漂移”到CD8-表达。在HIV-1感染的后期,CD4 + T细胞从病毒中耗尽, CD8 + T细胞由于慢性免疫激活而耗尽,我们形成了这样的假设:这些CD161 + DNTs的增加代表了人类免疫系统在产生促炎性免疫反应中的最终努力。为了测试这一点,我们从5名健康对照和8名HIV-1感染患者中分离了CD3 + T细胞,并分离了其RNA用于qRT-PCR的微阵列分析。我们预测,与健康对照相比,具有低CD4计数的HIV-1感染患者将具有明显的促炎性T细胞转录谱。 CD4计数低于100的4名HIV-1感染患者未显示大于2的阳性或阴性倍数变化,且未分析任何基因。在四位CD4计数在320至101之间的HIV患者中,有两名相对于IL-8基因有统计学意义的2倍变化(p = <0.001),而第三位患者与ap的表达非常接近= 0.073。 IL-8细胞因子是将多形核细胞(PMN)募集到急性炎症部位的主要趋化因子,已知IL-17可作用于多种组织以诱导IL-8的分泌。尽管只有CCL1和CCL2的变化大于2倍,但GATA-3,CCL20,MMP3,CCL1和CCL2也在这4例患者中明显上调。此外,在四位CD4计数高于100的患者中,有三位中有四个基因的变化是+2倍,尽管它们从未达到显着水平,但由于它们在每个患者的转录中均会复发,因此仍应提及个人资料。 IL-1β,IL-6,CXCL1和CXCL2是那些基因。已列出的所有基因均具有介导促炎性免疫反应的功能,这支持了我们最初的假设,即在HIV-感染后期,CD161 + DNTs的增加与促炎性转录谱的产生之间存在相关性。 1感染。这些CD161 + DNT很可能是人体诱导炎症反应的最终尝试。 (摘要由UMI缩短。)。

著录项

  • 作者

    Singleterry, Will Landry.;

  • 作者单位

    The University of Mississippi Medical Center.;

  • 授予单位 The University of Mississippi Medical Center.;
  • 学科 Health Sciences Immunology.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 104 p.
  • 总页数 104
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号